Adjuvant Treatment of Breast Cancer With 1-3 Aflicted Lymph Nodes
The purpose of this study is to determine whether a treatment with 4 cycles anthracycline + cyclophoshamide followed by administration of 4 cycles paclitaxel is more effective than therapy with 4 cy\<cles of anthracycline adminbistration followed by 4 cycles of paclitaxel
Breast Cancer
DRUG: Cyclophosphamide, Epirubicin, Paclitaxel|DRUG: Epirubicin, Paclitaxel, Filgrastim
progression-free time, every 3-6 months
toxicity|overall survival, 5 years
The purpose of this study is to determine whether a treatment with 4 cycles anthracycline + cyclophoshamide followed by administration of 4 cycles paclitaxel is more effective than therapy with 4 cy\<cles of anthracycline adminbistration followed by 4 cycles of paclitaxel